✦ LIBER ✦

Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas

✍ Scribed by Ding-Jen Lee; Dennis Cosmatos; Victor A. Marcial; Karen K. Fu; Marvin Rotman; Jay S. Cooper; Hernando G. Ortiz; Jonathan J. Beitler; Ross A. Abrams; Walter J. Curran; C. Norman Coleman; Todd H. Wasserman

Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 1012 KB
Volume: 32
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(95)00150-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of an rtog phase iii trial (rtog

Results of an rtog phase iii trial (rtog 85-27) comparing radiotherapy plus etanidazole (sr-2508) with radiotherapy alone for locally advanced head and neck carcinomas

✍ D.J. Lee; T. Pajak; V.A. Marcial; K. Fu; M. Rotman; J.S. Cooper; H.G. Ortiz; J.J 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Quality-adjusted survival analysis of Ra

Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: Phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinoma

✍ Andre A. Konski; Kathryn Winter; Bernard F. Cole; Kie-Kian Ang; Karen K. Fu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Abstract ## Background. To evaluate quality‐adjusted survival (QAS) of patients with locally advanced squamous cell carcinoma of the head and neck treated with 4 different radiation fractionation schedules. ## Methods. QAS was calculated using the quality‐adjusted time without toxicity or rel

Phase I and initial phase II results fro

Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck

✍ David L. Schwartz; R. Bruce Montgomery; Bevan Yueh; Michael Donahue; Yoshimi Anz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract ## BACKGROUND The current Phase I/II study assessed induction docetaxel/carboplatin given weekly for 4 weeks, followed by weekly docetaxel/carboplatin and concomitant boost radiotherapy (CB‐XRT) for locally advanced head and neck squamous cell carcinoma. ## METHODS Twenty patients wi